OR WAIT null SECS
July 08, 2021
June 14, 2021
Small companies that want to develop an environmental, social, and corporate governance (ESG) program should start the process by defining their goals and identifying the initiatives that their peers and competitors tend to focus on.
May 14, 2021
Elizabeth (EJ) Ashbourne, Executive Director of the Partnership for Quality Medical Donations (PQMD), discusses the role of the organization in advancing global health and highlights the benefits offered to members of the pharma industry.
April 21, 2021
Strategies to become a Certified B Corporation, and the benefits to the industry, its stakeholders, and the world.
March 11, 2021
Meaningful biopharma sustainability metrics are a crucial challenge.
January 13, 2021
Biopharma sustainability resolutions for a better 2021.
December 11, 2020
For many years, high energy use and its impact on the environment by businesses within the life sciences sector had been generally overlooked in national and global efforts to combat climate change. But with “carbon neutrality” the new buzzwords, how is the sector embracing this push for change?
Why major companies are stepping up environmental commitments.
November 16, 2020
SynBio opens new environmental sustainability possibilities for pharma.
Especially critical amid the continuing global pandemic, key metrics are laid out to help life sciences companies define, measure, and effectively communicate sustainability practices and progress—and build foundations for long-term business value.
